| 标题 |
[求助补充材料] [高分]
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoring |
| 网址 | |
| DOI |
10.1158/1078-0432.ccr-25-2461
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:Jiayao Ni; Yi Sun; Hao Cheng; Xinyuan Bai; Fan Tong; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)